VAERS reports by lot

GSK Varicella/Shingles lot 5YR3P: VAERS reports

34 VAERS reports list lot 5YR3P as a GSK Varicella/Shingles vaccine, received between 2023-01-20 and 2024-03-19. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
34
Reports
12%
Marked serious
0
With a death outcome
8
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction2626%
General / Systemic (non-local)1818%
Musculoskeletal1414%
Dermatological (non-injection-site)1313%
Cardiac / Cardiovascular99%
Neurological88%
Gastrointestinal55%
Psychiatric / Neuropsychiatric33%
Allergic / Anaphylactic22%
Respiratory11%

Where reports came from

U.S. state of the reporter, where given (top 12).

New York4
Indiana4
Wisconsin3
Maryland3
Pennsylvania2
Ohio2
Virginia2
Illinois2
Minnesota2
Massachusetts2
Michigan2
Rhode Island1

Reports by month received

2023-011
2023-0210
2023-0311
2023-043
2023-052
2023-063
2023-073
2024-031

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.